vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Hilltop Holdings Inc. (HTH). Click either name above to swap in a different company.
Hilltop Holdings Inc. is the larger business by last-quarter revenue ($300.5M vs $270.8M, roughly 1.1× HUTCHMED (China) Ltd). Hilltop Holdings Inc. runs the higher net margin — 13.0% vs 0.7%, a 12.3% gap on every dollar of revenue.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Hilltop Holdings Inc. is a financial holding company based in Dallas, Texas. It offers financial products and banking services through three primary subsidiaries: PlainsCapital Bank, PrimeLending, and HilltopSecurities.
HCM vs HTH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $270.8M | $300.5M |
| Net Profit | $2.0M | $39.0M |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | — |
| Net Margin | 0.7% | 13.0% |
| Revenue YoY | -16.5% | — |
| Net Profit YoY | -83.6% | -12.4% |
| EPS (diluted) | $0.00 | $0.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $300.5M | ||
| Q4 25 | $270.8M | $329.9M | ||
| Q3 25 | — | $330.2M | ||
| Q2 25 | $277.7M | $303.3M | ||
| Q1 25 | $324.5M | $318.5M | ||
| Q4 24 | — | $301.1M | ||
| Q3 24 | — | $305.5M | ||
| Q2 24 | $305.7M | $297.0M |
| Q1 26 | — | $39.0M | ||
| Q4 25 | $2.0M | $41.6M | ||
| Q3 25 | — | $45.8M | ||
| Q2 25 | $455.0M | $36.1M | ||
| Q1 25 | $11.9M | $42.1M | ||
| Q4 24 | — | $35.5M | ||
| Q3 24 | — | $29.7M | ||
| Q2 24 | $25.8M | $20.3M |
| Q1 26 | — | — | ||
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | -13.2% | 16.1% | ||
| Q3 25 | — | 18.4% | ||
| Q2 25 | -1.3% | 16.3% | ||
| Q1 25 | -5.0% | 18.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 13.9% | ||
| Q2 24 | -9.0% | 10.0% |
| Q1 26 | — | 13.0% | ||
| Q4 25 | 0.7% | 12.6% | ||
| Q3 25 | — | 13.9% | ||
| Q2 25 | 163.8% | 11.9% | ||
| Q1 25 | 3.7% | 13.2% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | — | 9.7% | ||
| Q2 24 | 8.4% | 6.8% |
| Q1 26 | — | $0.64 | ||
| Q4 25 | $0.00 | $0.68 | ||
| Q3 25 | — | $0.74 | ||
| Q2 25 | $0.52 | $0.57 | ||
| Q1 25 | $0.01 | $0.65 | ||
| Q4 24 | — | $0.55 | ||
| Q3 24 | — | $0.46 | ||
| Q2 24 | $0.03 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | — |
| Total DebtLower is stronger | $93.2M | $990.8M |
| Stockholders' EquityBook value | $1.2B | $2.2B |
| Total Assets | $1.8B | $15.7B |
| Debt / EquityLower = less leverage | 0.08× | 0.46× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.4B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $836.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $802.5M | — |
| Q1 26 | — | $990.8M | ||
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — |
| Q1 26 | — | $2.2B | ||
| Q4 25 | $1.2B | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | $1.2B | $2.2B | ||
| Q1 25 | $759.9M | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | $740.1M | $2.1B |
| Q1 26 | — | $15.7B | ||
| Q4 25 | $1.8B | $15.8B | ||
| Q3 25 | — | $15.6B | ||
| Q2 25 | $1.8B | $15.4B | ||
| Q1 25 | $1.3B | $15.8B | ||
| Q4 24 | — | $16.3B | ||
| Q3 24 | — | $15.9B | ||
| Q2 24 | $1.3B | $15.6B |
| Q1 26 | — | 0.46× | ||
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | — |
| Free Cash FlowOCF − Capex | $3.4M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 1.8% | — |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.2M | $-38.7M | ||
| Q3 25 | — | $273.0M | ||
| Q2 25 | $-72.9M | $-234.6M | ||
| Q1 25 | $40.3M | $5.8M | ||
| Q4 24 | — | $273.9M | ||
| Q3 24 | — | $515.6M | ||
| Q2 24 | $-39.8M | $-435.3M |
| Q1 26 | — | — | ||
| Q4 25 | $3.4M | $-55.5M | ||
| Q3 25 | — | $271.0M | ||
| Q2 25 | $-82.2M | $-234.6M | ||
| Q1 25 | $32.5M | $5.0M | ||
| Q4 24 | — | $266.8M | ||
| Q3 24 | — | $513.8M | ||
| Q2 24 | $-49.9M | $-437.3M |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | -16.8% | ||
| Q3 25 | — | 82.1% | ||
| Q2 25 | -29.6% | -77.4% | ||
| Q1 25 | 10.0% | 1.6% | ||
| Q4 24 | — | 88.6% | ||
| Q3 24 | — | 168.2% | ||
| Q2 24 | -16.3% | -147.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.8% | 5.1% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | 3.3% | 0.0% | ||
| Q1 25 | 2.4% | 0.3% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | 3.3% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.21× | -0.93× | ||
| Q3 25 | — | 5.96× | ||
| Q2 25 | -0.16× | -6.50× | ||
| Q1 25 | 3.38× | 0.14× | ||
| Q4 24 | — | 7.71× | ||
| Q3 24 | — | 17.36× | ||
| Q2 24 | -1.54× | -21.41× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
HTH
| Noninterest Income | $188.4M | 63% |
| Net Interest Income | $112.1M | 37% |